appScorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Poly Medicure Ltd
POLYMED
Price Chart
Scorecard
Performance
AvgPrice return has been average, nothing exciting
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key MetricsEdit
Forecast & RatingsDetailed Forecast
Analysts have suggested that investors can buy this stock
Company Profile
Poly Medicure Limited is engaged in the manufacturing and sale of medical devices.
PeersCompare with peers
Tarsons Products Ltd
Borosil Scientific Ltd
Balaxi Pharmaceuticals Ltd
Universus Photo Imagings Ltd
Constronics Infra Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Financial TrendFinancial statements
Holdings TrendDetailed holdings
Low Pledged Promoter HoldingLower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
Increased Mutual Fund HoldingIncreasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock
In last 3 months, mutual fund holding of the company has increased by 1.05%
Recent NewsAll news
Hmm, looks like data is unavailable here. Please come back after some timeRecent EventsAll events
Board Meeting Intimation
POLY MEDICURE LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and ESOP/Other business. | Download
POLY MEDICURE LIMITED has informed the Exchange about Board Meeting to be held on 28-Oct-2024 to consider and approve the Quarterly Unaudited Financial results of the Company for the period ended June 2024 and ESOP/Other business. | Download
Cash Dividend
Final • Div/Share: ₹ 3
Increased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has increased by 9.41%